PROGRESS IN T-CELL IMMUNE RESEARCH ON HYPERLIPIDEMIC PANCREATITIS

Area of Science:

• Immunology
• Metabolic Disorders
• Gastroenterology

Background:

• T cells are integral to the immune response in hyperlipidemic pancreatitis.
• Dysregulated lipid metabolism significantly impacts T-cell function.
• Hyperlipidemia exacerbates pancreatic inflammation through mechanisms like ferroptosis and pyroptosis.

Purpose of the Study:

• To elucidate the role of T cells in hyperlipidemic pancreatitis.
• To understand how lipid metabolism affects T-cell function in this condition.
• To explore potential T-cell-targeted immunotherapies.

Main Methods:

• Analysis of T-cell activation and differentiation (Th2, regulatory T cells, central memory T cells).
• Investigation of hyperlipidemia-induced inflammatory pathways (ferroptosis, pyroptosis).
• Review of existing and potential immunotherapeutic strategies.

Main Results:

• Acute pancreatitis shows rapid T-cell activation and Th2 differentiation linked to severity.
• CD4+ T cells contribute to inflammation, and IL-6 drives systemic T-cell activation.
• Chronic pancreatitis involves regulatory T cells and increased central memory T cells.
• Hyperlipidemia worsens pancreatic inflammation via ferroptosis and fatty acid-induced pyroptosis.

Conclusions:

• T cells are key players in hyperlipidemic pancreatitis, with their behavior varying between acute and chronic phases.
• Lipid metabolism dysregulation and hyperlipidemia significantly drive disease pathogenesis.
• Targeting T cells presents a promising, albeit challenging, therapeutic strategy for hyperlipidemic pancreatitis.